Cargando…

Anti–PD-L1 Treatment Induced Central Diabetes Insipidus

CONTEXT: Immune checkpoint inhibitors, including anti–programmed cell death protein 1 (PD-1), anti–programmed cell death protein ligand 1 (PD-L1), and anti–cytotoxic T-lymphocyte antigen 4 (anti-CTLA4) monoclonal antibodies, have been widely used in cancer treatment. They are known to cause immune-r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Chen, Tella, Sri Harsha, Del Rivero, Jaydira, Kommalapati, Anuhya, Ebenuwa, Ifechukwude, Gulley, James, Strauss, Julius, Brownell, Isaac
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Endocrine Society 2017
Materias:	Case Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5800826/ https://www.ncbi.nlm.nih.gov/pubmed/29220526 http://dx.doi.org/10.1210/jc.2017-01905

Ejemplares similares

Thyrotoxic Periodic Paralysis: An Underdiagnosed and Under-recognized Condition
por: Tella, Sri Harsha, et al.
Publicado: (2015)

Profile of Abaloparatide and Its Potential in the Treatment of Postmenopausal Osteoporosis
por: Tella, Sri Harsha, et al.
Publicado: (2017)

Evaluating the Safety and Efficacy of Nivolumab in Patients with Advanced Hepatocellular Carcinoma: Evidence to Date
por: Tella, Sri Harsha, et al.
Publicado: (2019)

First-Line Targeted Therapy for Hepatocellular Carcinoma: Role of Atezolizumab/Bevacizumab Combination
por: Tella, Sri Harsha, et al.
Publicado: (2022)

Potential Role of Metabolic Intervention in the Management of Advanced Differentiated Thyroid Cancer
por: Tella, Sri Harsha, et al.
Publicado: (2017)

Immunotherapy in Hepatocellular Carcinoma: Is There a Light at the End of the Tunnel?
por: Mahipal, Amit, et al.
Publicado: (2019)

FGFR Inhibitors in Oncology: Insight on the Management of Toxicities in Clinical Practice
por: Kommalapati, Anuhya, et al.
Publicado: (2021)

Contemporary Management of Localized Resectable Pancreatic Cancer
por: Kommalapati, Anuhya, et al.
Publicado: (2018)

Systemic Therapy in Advanced Hepatocellular Carcinoma: Patient Selection and Key Considerations
por: Storandt, Michael H, et al.
Publicado: (2022)

Upper Limb Phlegmasia Cerulea Dolens Secondary to Heparin-induced Thrombocytopenia Leading to Gangrene
por: Kommalapati, Anuhya, et al.
Publicado: (2018)

Dual targeting of TGF-β and PD-L1 via a bifunctional anti-PD-L1/TGF-βRII agent: status of preclinical and clinical advances
por: Lind, Hanne, et al.
Publicado: (2020)

A Case Report of Sequential Use of a Yeast-CEA Therapeutic Cancer Vaccine and Anti-PD-L1 Inhibitor in Metastatic Medullary Thyroid Cancer
por: Del Rivero, Jaydira, et al.
Publicado: (2020)

Diffuse lichen planus-like keratoses and clinical pseudo-progression associated with avelumab treatment for Merkel cell carcinoma, a case report
por: Cardis, Michael A., et al.
Publicado: (2019)

Aspirin and Statin Use and the Risk of Gallbladder Cancer
por: Prasai, Kritika, et al.
Publicado: (2021)

Central diabetes insipidus
por: Arima, Hiroshi, et al.
Publicado: (2016)

Product review: avelumab, an anti-PD-L1 antibody
por: Collins, Julie M., et al.
Publicado: (2018)

PSUN169 Vitamin C Renal Leak in Diabetes
por: Ebenuwa, Ifechukwude, et al.
Publicado: (2022)

The Impact of Ramucirumab Treatment on Survival and Quality of Life in Patients with Gastric Cancer
por: Mehta, Rutika, et al.
Publicado: (2020)

Hypernatraemia in the neurointensive care unit: central diabetes insipidus and noncentral diabetes insipidus
por: Spatenkova, V, et al.
Publicado: (2009)

PSUN168 The relationship between vitamin C concentrations and reduced red blood cell deformability in diabetes
por: Violet, Pierre-Christian, et al.
Publicado: (2022)

Central diabetes insipidus and burn trauma
por: Kopel, Jonathan, et al.
Publicado: (2022)

Idiopathic partial central diabetes insipidus
por: Fabre, Larissa, et al.
Publicado: (2023)

Oxcarbazepine Therapy for Complete Central Diabetes Insipidus
por: Abdallah, Basmah, et al.
Publicado: (2018)

Pregnancy complicated by central diabetes insipidus and oligohydramnios
por: Imaizumi, Karin, et al.
Publicado: (2021)

FRI355 Hypokalemia-induced Nephrogenic Diabetes Insipidus In A Patient With Medullary Thyroid Carcinoma And Paraneoplastic Cushing’s Syndrome
por: Jhawar, Sakshi, et al.
Publicado: (2023)

Hypopituitarism and Central Diabetes Insipidus Caused by Central Nervous System Lymphoma
por: Zenimaru, Yasuo, et al.
Publicado: (2018)

Metastatic Prostate Adenocarcinoma Presenting Central Diabetes Insipidus
por: Yılmaz, Hakkı, et al.
Publicado: (2012)

Transient central diabetes insipidus following ischemic stroke
por: Jayaraman, Muthukrishnan, et al.
Publicado: (2013)

Central Diabetes Insipidus after Staged Spinal Surgery
por: Rosenbaum, Benjamin P., et al.
Publicado: (2013)

Cerebral Malaria: An Unusual Cause of Central Diabetes Insipidus
por: Premji, Resmi, et al.
Publicado: (2016)

Causes and Follow-Up of Central Diabetes Insipidus in Children
por: Liu, Wendong, et al.
Publicado: (2019)

A Case of Central Diabetes Insipidus Secondary to Neurosarcoidosis
por: Johns, Colleen E, et al.
Publicado: (2020)

Transient Central Diabetes Insipidus after Discontinuation of Vasopressin
por: Carman, Nathaniel, et al.
Publicado: (2019)

Concurrent Central Diabetes Insipidus and Acute Myeloid Leukemia
por: Pritzl, Stephanie L., et al.
Publicado: (2021)

Pituitary Metastasis Presenting With Central Diabetes Insipidus and Panhypopituitarism
por: Parthasarathy, Sahana, et al.
Publicado: (2021)

Acute Myeloid Leukemia Leading to Central Diabetes Insipidus
por: Wojeck, Brian, et al.
Publicado: (2021)

Type 2M Von Willebrand Disease: A Case Report
por: Ghosh, Sudeshna, et al.
Publicado: (2018)

Lamotrigine-induced SIADH in a child with central diabetes insipidus
por: Kılıç, Huseyin, et al.
Publicado: (2011)

MR Imaging of Central Diabetes Insipidus: A Pictorial Essay
por: Shin, Ji Hoon, et al.
Publicado: (2001)

Central Adrenal Insufficiency and Diabetes Insipidus Misdiagnosed as Severe Depression
por: Hiroi, Naoki, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_1692msvk50irl3978kogr7q45h